Status:
UNKNOWN
Methylene Blue and Microcirculation in Septic Shock
Lead Sponsor:
Cairo University
Conditions:
Septic Shock
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This trial aims to identify the effects of methylene blue infusion on the the micro-circulation in patients with septic shock. The investigators will evaluate various indices of micro-circulation such...
Detailed Description
The mortality rate of patients with septic shock remains very high. Arterial hypotension, related to arteriolar vasodilation and myocardial depression are the mainstays of septic shock pathology. At ...
Eligibility Criteria
Inclusion
- Septic shock
- The patient is on norepinephrine infusion
Exclusion
- Elevated serum creatinine (above 1.4 mg/dL)
- Pregnancy
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04295993
Start Date
March 10 2020
End Date
September 20 2020
Last Update
March 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt